Inhibitors of epidermal growth factor receptor kinase and of cyclin- dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3741-3750

  Ben Bassat, Hannah ^a   Rosenbaum Mitrani, Stella ^a   Hartzstark, Zippora ^a   Shlomai, Zippora ^a   Kleinberger Doron, Nurit ^b   Gazit, Aviv ^b   Plowman, Gregory ^c   Levitzki, Rubina ^a   Tsvieli, Rimona ^a   Levitzki, Alexander ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AG 555; AMPHIREGULIN; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKERATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FILAGGRIN; ONCOPROTEIN; PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; GENE EXPRESSION; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; UTERINE CERVIX CANCER;

ANTIBODIES; APOPTOSIS; BENZYLIDENE COMPOUNDS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; KERATINOCYTES; NITRILES; PAPILLOMAVIRIDAE; PHOSPHORYLATION; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYRPHOSTINS;

EID: 14444280165     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. zur Hausen, H. Herpes simplex virus in human genital cancer. Int. Rev. Exp. Pathol., 25: 307-326, 1983.
2. Pfister, H. Biology and Biochemistry of papilloma viruses. Rev. Physiol. Biochem. Pharmacol., 99: 111-181, 1984.
3. Parkin, D. M., Laara, E., and Muir, C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41: 184-187, 1988.
4. Durst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N. E., and Gissmann, L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papilloma virus type 16 DNA. Oncogene, 1: 251-256, 1987.
5. Brocker, T. R., and Botcham, M. Cancer Cells: DNA Tumor Viruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp. 17-36, 1986.
6. Matleashewski, G., Schmeider, J., Banks, L., Jones, N., Murray, A., and Crawford, L. Human papilloma virus 16 DNA cooperates with activated ras in transformed mammary cells. EMBO J. 6: 1741-1746, 1987.
7. Munger, K., Phelps, W. C., Rubb, B., Howley, P. M., and Schlegel, R. The E6 and E7 genes of HPV16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4471-4421, 1989.
8. Watanabe, S. Kanda, T., and Yoshike, K. Human papilloma virus type 16 transformation of primary human embryonic fibroblasts requires expression of open reacting frames E6 and E7. J. Virol., 63: 965-969, 1989.
9. zur Hausen, H. Papilloma viruses in human cancers. Mol. Carcinogen., 1: 147-150, 1988.
10. Durst M., Glitz, D., Schneider, A., and zur-Hausen, H. Human papilloma virus type 16 give expression and DNA replication in cervical neoplastic: analysis by in situ hybridization. Virology, 189: 132-140, 1992.
11. Stoler, M., Rhodes, C. R., Whitebeck, A., Wolinsky, S. M., Chow, L. T., and Brocker, T. R. Human papilloma virus type 16 and 18 gene expression in cervical neoplasis. Hum. Pathol., 23: 117-128, 1992.
12. Woodworth, C. D., McMullin, E., Iglesias, M., and Plowman, G. D. Inerleukin 1a and TNFα stimulate autocrine amphiregulin expression and proliferation of human papilloma-immortalized and carcinoma-derived cervical epithelium cells. Proc. Natl. Acad. Sci. USA, 92: 2840-2844, 1995.
13. Malejczyk, J., Malejczyk, M., Majewski, S., Breitburd, F., Luger, T. A., Jablonska, S., and Orth, G. Increased tumorigenicity of human keratinocytes harboring HPV16 is associated with resistance to endogenous TNFα mediated growth inhibition. Int. J. Cancer, 56: 593-598, 1994.
14. Dvir, A., Milner, Y., Chomsky, O., Gilon, C., Gazit, A., and Levitzki, A. The inhibition of EGF dependent proliferation of keratinocytes harboring HPV16 is associated with resistance to endogenous TNFα mediated growth inhibition. J. Cell Biol., 113: 857-865, 1991.
15. Ben-Basat, H., Vardy, D. V., Gazit, A., Klaus, S. N., Chaouat, M., Hartzstark, Z., and Levitzki, A. Tyrphostins suppress the growth of psoriatic keratinocytes. Exp. Dermatol., 4: 82-88, 1995.
16. Osherov, N., and Levitzki, A. Epidermal growth factor dependent activation of Src family kinases. Eur. J. Biochem., 225: 1047-1053, 1994.
17. Ward, W. H. J., Cook, P. N., Slater, A. M., Davies, D. H., Holdgat, G. A., and Green, L. R. Epidermal growth factor receptor tyrosine kinase: investigation of catalytic mechanism, structure-based searching, and discovery of a potent inhibitor. Biochem. Pharmacol., 48: 659-666, 1994.
18. Gazit A., Chen, J., App, H., McMahon, G., Hirth, P., Chen, I., and Levitzki A. Tyrphostin 4: highly potent inhibitors of EGF receptor kinase structure activity relationship: study of 4 anilido quinazolines. Bioorg. & Med. Chem. Lett., 4: 1203-1207, 1996.
19. Rheinwald, J. G., and Green, H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature (Lond.), 265: 421-424, 1977.
20. Mitrani-Rosenbaum, S., and Tsvieli, R. Differential cooperation of a carcinogen with human papilloma virus type 6 and 16 DNAs in in vitro oncogenic transformation. Intervirology, 33: 76-85, 1992.
21. Scheffner, M., Munger, K. Byrine, J., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci USA, 88: 5523-5527, 1991.
22. Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gilon, C., and Levitzki, A. Tyrphostin II: heterocyclic and α-substituted benzonemalononitrile tyrphostins as potent inhibitors of EGF receptor and Erb B-2 1/neu tyrosine kinases. J. Med. Chem., 34: 1897-1907, 1991.
23. Osherov, N., Gazit, A., Gilon, C., and Levitzki, A. Selective inhibition of the EGF and HER2/Neu receptors by tyrphostins. J. Biol. Chem., 268: 11134-11142. 1993.
24. Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. Specific inhibitor of the EGF receptor kinase. Science (Washington DC), 265:, 1093-1095, 1994.
25. Goldman, R., and Bar-Shavit, Z. Dual effect of normal stimulated macrophages and their conditioned media on target cell proliferation. J. Natl. Cancer Inst., 63: 1004-1016, 1979.
26. Sizemore, N., and Kurke, E. A., Human HPV 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and EGF receptor expression. Cancer Res., 53: 4511-4517, 1993.
27. Zyzak, L, L., MacDonald, L. M., Batova, A., Forand, R., Creek, K. E., and Pirisi, L, Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes. Cell Growth & Differ., 5: 537-547, 1994.
28. Osherov, N., and Levitzki, A. Tyrphostin 494 blocks Cdk 2 activation. FEBS Lett., in press, 1997.